
    
      -  Brief Protocol: Treat the patients taking Taxotere+Epirubicin +Cyclophosphamide (TEC)
           treatment or Taxotere+Epirubicin (TE)treatment chemotherapy with the study medicine or
           positive control during the period between two chemotherapy treatments.

        -  Targeted patients: breast cancer

        -  Subjects were randomly divided into two groups. The test group received recombinant
           human serum albumin / granulocyte thorns for injection Stimulant fusion protein 2.4mg
           treatment. Positive control group received recombinant human granulocyte colony stimuli
           Factor injection therapy

        -  Number of patients: 80
    
  